ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 7 analysts with an average price target of $74.17. This is a potential upside of $65.68 (773.62%) from yesterday's end of day stock price of $8.49.

Atara Biotherapeutics's activity chart (see below) currently has 63 price targets and 73 ratings on display. The stock rating distribution of ATRA is 50% BUY, 20% SELL and 30% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.24% with an average time for these price targets to be met of 74.8 days.

Highest price target for ATRA is $18, Lowest price target is $17, average price target is $74.17.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 22-Jan-2025. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 10 are a BUY (50%), 4 are a SELL (20%), 6 are a HOLD (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

8 days ago
(22-Jan-2025)

1/4 (25%)

$376.5 (88.90%)

175

Buy

$17

$8.78 (106.81%)

$21

13 days ago
(17-Jan-2025)

2/5 (40%)

$9.17 (117.11%)

59

Hold

$18

$9.78 (118.98%)

5 months 14 days ago
(16-Aug-2024)

1/4 (25%)

$10.99 (156.78%)

143

Sell

$35

$26.78 (325.79%)

$75

1 years 5 months 9 days ago
(21-Aug-2023)

13/13 (100%)

$-0.25 (-0.71%)

298

Sell

2 years 5 months 21 days ago
(09-Aug-2022)

3/3 (100%)

$0.54 (4.01%)

12

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 74.8 days on average for the stock forecasts to be realized with a an average price target met ratio 39.24

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $616.78

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Salveen Richter with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?